Samsung Epis Holdings Co Ltd
Samsung Epis Holdings Co Ltd has a market price of 488,000 KRW, with a market capitalization of 12.14 trillion KRW. The company's price-to-book ratio is 2.1, and its price-to-tangible-book ratio is also 2.1, indicating a relatively high valuation compared to its book value. The enterprise value to EBITDA ratio is -180.80, which is significantly negative, reflecting the company's current operating losses. The enterprise value to revenue ratio is 49.23, suggesting a high valuation relative to its revenue. The company's profitability metrics are concerning. The return on equity is -0.54%, and the return on assets is -0.41%, both indicating a negative return on invested capital. The gross profit margin is 36.64%, but the operating margin is -27.23%, and the net margin is -12.47%, all of which are below the industry median for profitability metrics. The debt-to-equity ratio is 0.07, which is relatively low, but the company's current ratio is 1.36, indicating a moderate level of liquidity. Samsung Epis Holdings Co Ltd's revenue is concentrated in a single business segment, as disclosed in its financial statements. There is no geographic diversification provided in the available data, suggesting that the company's revenue is primarily derived from a single region. This lack of diversification could pose a concentration risk if the company's primary market experiences economic downturns or regulatory changes. The company's growth trajectory is mixed. The current fiscal year is expected to show a decline in revenue, with a negative outlook for the next fiscal year as well. The operating cash flow is negative at -103.74 billion KRW, and the free cash flow is also negative at -3.26 billion KRW. The capital expenditure is -39.99 billion KRW, indicating significant investment in the business. However, the company's net income is negative at -31.38 billion KRW, and the operating income is also negative at -68.53 billion KRW. The risk assessment for Samsung Epis Holdings Co Ltd indicates a medium level of liquidity risk and a low level of dilution risk. The company's key financial flags include a negative net cash position after subtracting total debt, which could impact its ability to meet short-term obligations. The dilution potential is low, and there are no significant adjustments applied to the valuation metrics. Recent events and disclosures include analyst estimates with a mean price target of 695,000 KRW and a median price target of 695,000 KRW. The mean recommendation is 2.33, indicating a hold rating. There are two buy recommendations and one hold recommendation, with no strong buy or strong sell ratings. These analyst estimates suggest a cautious outlook for the company's stock.
Business. Samsung Epis Holdings Co Ltd operates in the Biotechnology & Medical Research industry, focusing on Pharmaceuticals & Medical Research.
Classification. The company is classified under the Healthcare economic sector, with a high confidence level of 0.92 in its placement within the Biotechnology & Medical Research industry.
- Samsung Epis Holdings Co Ltd has a high price-to-book ratio of 2.1, indicating a premium valuation relative to its book value.
- The company's profitability metrics, including a negative return on equity and return on assets, suggest poor financial performance.
- The company's revenue is concentrated in a single business segment, posing a concentration risk.
- Analyst estimates suggest a cautious outlook, with a mean price target of 695,000 KRW and a hold recommendation.
- The company's liquidity position is moderate, with a current ratio of 1.36, but its net cash position is negative after subtracting total debt.
- --
- ## RATIONALES
- ```json
- Net cash is negative after subtracting total debt.